サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：構造的心臓イメージングの世界市場（2022年～2029年）
市場調査レポート
商品コード
1065219

構造的心臓イメージングの世界市場（2022年～2029年）

Global Structural Heart Imaging Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
構造的心臓イメージングの世界市場（2022年～2029年）
出版日: 2022年05月07日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の構造的心臓イメージング市場について調査分析し、市場力学、業界分析、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 世界の構造的心臓イメージング市場の調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 世界の構造的心臓イメージング市場－市場の定義と概要

第3章 世界の構造的心臓イメージング市場－エグゼクティブサマリー

  • 市場の内訳：イメージングモダリティ別
  • 市場の内訳：施術タイプ別
  • 市場の内訳：アプリケーション別
  • 市場の内訳：エンドユーザー別
  • 市場の内訳：地域別

第4章 世界の構造的心臓イメージング市場－市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界の構造的心臓イメージング市場－業界分析

  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • アンメットニーズ

第6章 世界の構造的心臓イメージング市場－COVID-19分析

  • 市場のCOVID-19分析
    • COVID-19以前の市場シナリオ
    • 現在のCOVID-19の市場シナリオ
    • COVID-19以後の市場シナリオ/将来の市場シナリオ
  • COVID-19における価格の力学
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界の構造的心臓イメージング市場：イメージングモダリティ別

  • イントロダクション
    • 市場規模分析、および前年比成長分析（％）：イメージングモダリティ別
    • 市場魅力指数：イメージングモダリティ別
  • 心エコー検査*
    • イントロダクション
    • 市場規模分析、100万米ドル（2020年～2029年）、および前年比成長分析（％）（2021年～2029年）
  • 血管造影
    • CT
    • MRI

第8章 世界の構造的心臓イメージング市場：施術タイプ別

  • イントロダクション
    • 市場規模分析、および前年比成長分析（％）：施術タイプ別
    • 市場魅力指数：施術タイプ別
  • 経カテーテル大動脈弁置換術（TAVR）*
    • イントロダクション
    • 市場規模分析、100万米ドル（2020年～2029年）、および前年比成長分析（％）（2021年～2029年）
  • 外科的大動脈弁置換術（SAVR）
  • 経カテーテル僧帽弁修復術（TMVR）
  • 左心耳閉鎖（LAAC）
  • 弁輪形成術
  • 弁形成術
  • その他

第9章 世界の構造的心臓イメージング市場：アプリケーション別

  • イントロダクション
    • 市場規模分析、および前年比成長分析（％）：アプリケーション別
    • 市場魅力指数：アプリケーション別
  • 診断*
    • イントロダクション
    • 市場規模分析、100万米ドル（2020年～2029年）、および前年比成長分析（％）（2021年～2029年）
  • 手術

第10章 世界の構造的心臓イメージング市場：エンドユーザー別

  • イントロダクション
    • 市場規模分析、および前年比成長分析（％）：エンドユーザー別
    • 市場魅力指数：エンドユーザー別
  • 病院*
    • イントロダクション
    • 市場規模分析、100万米ドル（2020年～2029年）、および前年比成長分析（％）（2021年～2029年）
  • 専門クリニック
  • 心臓センター
  • 診断センター
  • 外来手術センター
  • その他

第11章 世界の構造的心臓イメージング市場：地域別

  • イントロダクション
    • 市場規模分析、100万米ドル（2020年～2029年）、および前年比成長分析（％）（2021年～2029年）：地域別
    • 市場魅力指数：地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東とアフリカ

第12章 世界の構造的心臓イメージング市場－競合情勢

  • 主な開発と戦略
  • 企業シェア分析
  • 製品のベンチマーク
  • 注目すべき主要企業のリスト

第13章 世界の構造的心臓イメージング市場－企業プロファイル概要

  • Boston Scientific Corporation*
    • 企業概要
    • 製品ポートフォリオおよび説明
    • 主要ハイライト
    • 財務概要
  • Circle Cardiovascular Imaging Inc.
  • Absolute Medical Services, Inc.
  • Pie Medical Imaging B.V.
  • Siemens Healthineers GmbH
  • Cardinal Health Inc.
  • Koninklijke Philips NV
  • GE HealthCare
  • Neusoft Medical Systems
  • Shimadzu Corporation

第14章 世界の構造的心臓イメージング市場－DataM

  • 付録
  • 当社・アプリケーションについて
  • お問い合わせ
目次
Product Code: DMMI4868

Market Overview

The global structural heart imaging market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Structural heart imaging (SHI) is a cardiology field that deals with valvular and non-valvular heart disease. SHI is a molecular imaging technology that is used to screen the heart. This method entails using high-resolution cameras to create different images of the heart's inner components, which aid in the proper diagnosis of the patient's condition. The two most popular imaging techniques that closely analyze the heart structure to reveal narrowing or blockage of blood arteries are echocardiograms and angiography (MRI, CT, etc.)

Market Dynamics

Significant advances in structural heart interventions are expected to drive market growth.

Structural heart disease intervention is a game-changing breakthrough that has already displaced open surgery and enabled the treatment of a larger number of patients at a reduced cost. Significant progress has been made in structural cardiac interventions over the previous decade. The advancements in interventions and imaging are inextricably linked, from transcatheter aortic and pulmonic valve replacement to left atrial appendage occlusion procedures, percutaneous mitral repair techniques, and, more recently, transcatheter mitral valve replacement and tricuspid interventions. The commercial availability of 3-dimensional (3D) echocardiography, for instance, improved the efficiency, precision, and adaptability of the edge-to-edge repair technique. The collaboration of ultrasound and device firms continues to fuel breakthroughs in imaging that can then assist drive device innovation, thanks in part to imaging groups like the American Society of Echocardiography. Because of the imaging-intensive nature of all of these procedures, imagers must be familiar with a wide range of anatomical targets, modern imaging techniques, and the execution of numerous procedural interventions. Imagers have proven crucial to the field's continuous progress due to this information foundation. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

Strict regulatory guidelines for equipment used in structural heart imaging, a lack of awareness regarding cardiac-specific structural imaging, and higher costs are some of the factors due to which the market is expected to hamper the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. COVID-19 patients often have symptoms and signs of a respiratory tract infection, although cardiac manifestations, such as indicators of myocardial damage, are also prevalent. Myocardial injury in COVID-19 can be caused by an oxygen supply-demand imbalance resulting from hypoxia, hypoperfusion, tachycardia, microvascular and macrovascular thrombosis, or inflammation-related injury (especially in the setting of underlying structural heart disease or coronary atherosclerosis). Imaging aids in the early detection of disease in individuals with underlying cardiovascular disorders and the detection of cardiovascular consequences in people who have already been infected with SARS-CoV-2. Although symptoms of cardiac failure can be easily diagnosed using chest radiography, chest CT, and echocardiography, the best way to examine myocardial injury is with a cardiac MRI.

Moreover, the growing body of evidence indicating a high prevalence of cardiac involvement in COVID-19 patients warrants MRI in this patient population. In contrast, there is physical contact during imaging of the COVID-19 patients. Therefore, there are chances of spreading the virus, and the government has come out with guidelines during imaging(MRI, CT, and others). Additionally, the pandemic is interrupting the supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Angiogram segment is expected to hold the largest market share in structural heart imaging market

The angiogram segment is expected to dominate in 2020. The segment's growth is benefited because demand for various imaging modalities is projected to rise as the need for diagnostic and effective imaging for detecting SHDs, particularly CHDs, grows. Moreover, Angiogram is further segmented into MRI and CT. In the anatomic and functional evaluation of cardiovascular disease, MRI is a critical diagnostic technique. 2D phase-contrast (2D-PC) MRI has been used in several procedures for blood flow quantification. Flow in four dimensions MRI is a volumetric acquisition that records the vector field of blood flow and anatomic pictures in a time-resolved manner. Compared to 2D-PC, it also makes acquisition easier and allows for a more precise and thorough hemodynamic assessment. With advancements in accelerated imaging, 4D flow MRI scanning times have been greatly reduced while image quality has been maintained, allowing this technology to move from research to everyday clinical practice. 4D flow MRI will likely become an essential component of cardiac imaging in practices dealing with congenital and acquired structural heart disease as experience grows, and 4D flow sequences and postprocessing software become more widely available.

Moreover, the use of advanced parallel imaging techniques like k-t GRAPPA has resulted in scan times that are more realistic, such as 8-12 minutes for 4D flow MRI of the aorta and 10-20 minutes for complete heart coverage. As a result, using 4D flow MRI in a clinical setting has become increasingly practicable, as seen by an increase in recent reports on the technique's utility in patient studies for measuring cardiac and vascular hemodynamics. Thus, the market is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global structural heart imaging market

In 2020, North America accounted for the highest revenue share. The increasing prevalence of Congenital heart defects, increasing demand for technologically improved technologies for the treatment of Structural Heart Disease, increased lifestyle change adoption, increased structural disease awareness, more preventative care, favorable government policies, clinical trials, and product launches by the key players in the region are some of the factors due to which the market is expected to boost in the forecast period. For instance, according to the Centers for Disease Control and Prevention, The most frequent birth defects are congenital heart defects (CHDs), and babies are born with these problems. CHDs affect nearly 1% of-or about 40,000-births per year in the United States. Some CHDs, particularly mild forms, is growing in prevalence (the number of kids born with a heart defect divided by the total number of births), while the prevalence of other types has remained consistent. A ventricular septal defect is the most frequent type of heart abnormality (VSD). About 1 in 4 babies with CHD have a critical CHD. Infants with critical CHDs generally need surgery or other procedures in their first year of life.

Moreover, NuVera Medical, Inc. announced positive results from its non-randomized, single-center First-In-Human (FIH) study in October 2020, which looked at the NuVision ICE Catheter's feasibility in visualizing anatomical structures in patients undergoing structural heart procedures such as mitral or tricuspid valve repairs or LAAC. With improved 4D ICE imaging, the business hopes to improve the efficacy of transcatheter cardiac treatments. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Competitive Landscape

Major key players in the structural heart imaging market are Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Absolute Medical Services, Inc., Pie Medical Imaging B.V., Siemens Healthineers GmbH, Cardinal Health Inc., Koninklijke Philips NV, GE HealthCare, Neusoft Medical Systems and Shimadzu Corporation.

Siemens Healthineers AG:

Overview:

Siemens Healthineers AG (formerly Siemens Healthcare, Siemens Medical Solutions, Siemens Medical Systems) is the parent company for several medical technology companies. The company dates its early beginnings in 1847 to a small family business in Berlin, co-founded by Werner von Siemens. The name Siemens Medical Solutions was adopted in 2001, and the change to Siemens Healthcare was made in 2008. In May 2016, the business operations of Siemens Healthcare GmbH were rebranded by Siemens Healthineers. The company is into manufacturing products including Angiography and Interventional X-ray Systems. Computed Tomography, Radiation Oncology, Laboratory Diagnostics Molecular Diagnostics, Molecular Imaging, Magnetic Resonance Imaging Point-of-Care Diagnostics, Refurbished Systems, Services, Syngo Imaging Software, Ultrasound and X-ray Products.

Product Portfolio:

MAGNETOM Free.Max - Open Bore MRI Scanner: MAGNETOM Free. Max is the most compact whole-body MRI, and with DryCool technology, provides a virtually helium-free infrastructure. MAGNETOM Free. Max radically simplifies infrastructure requirements to break down the barriers imposed by siting constraints.

Why Purchase the Report?

Visualize the composition of the structural heart imaging market segmentation by imaging modality, procedure type, application, end user and region highlighting the key commercial assets and players.

Identify commercial opportunities in structural heart imaging market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of structural heart imaging market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global structural heart imaging market report would provide an access to an approx. 45+market data table, 40+figures and 200pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Structural Heart Imaging Market - By Imaging Modality

Echocardiogram

Angiogram

CT

MRI

Global Structural Heart Imaging Market - By Procedure Type

Transcatheter Aortic Valve Replacement (TAVR)

Surgical Aortic Valve Replacement (SAVR)

Transcatheter Mitral Valve Repair (TMVR)

Left Atrial Appendage Closure (LAAC)

Annuloplasty

Valvuloplasty

Others

Global Structural Heart Imaging Market - By Application

Diagnosis

Surgery

Global Structural Heart Imaging Market - By End user

Hospitals

Specialty Clinics

Cardiac Centers

Diagnostic Centers

Ambulatory Surgical Centers

Others

Global Structural Heart Imaging Market - By Region

North America

South America

Europe

Asia

Middle East & Africa

Table of Contents

1. Global Structural Heart Imaging Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Structural Heart Imaging Market - Market Definition and Overview

3. Global Structural Heart Imaging Market - Executive Summary

  • 3.1. Market Snippet by Imaging Modality
  • 3.2. Market Snippet by Procedure Type
  • 3.3. Market Snippet by Application
  • 3.4. Market Snippet by End User
  • 3.5. Market Snippet by Region

4. Global Structural Heart Imaging Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Significant advances in structural heart interventions are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Strict regulatory guidelines for equipment used in structural heart imaging are expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Structural Heart Imaging Market - Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Unmet Needs

6. Global Structural Heart Imaging Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Structural Heart Imaging Market - By Imaging Modality

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 7.1.2. Market Attractiveness Index, By Imaging Modality Segment
  • 7.2. Echocardiogram*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Angiogram
    • 7.3.1. CT
    • 7.3.2. MRI

8. Global Structural Heart Imaging Market - By Procedure Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type
    • 8.1.2. Market Attractiveness Index, By Procedure Type Segment
  • 8.2. Transcatheter Aortic Valve Replacement (TAVR)*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Surgical Aortic Valve Replacement (SAVR)
  • 8.4. Transcatheter Mitral Valve Repair (TMVR)
  • 8.5. Left Atrial Appendage Closure (LAAC)
  • 8.6. Annuloplasty
  • 8.7. Valvuloplasty
  • 8.8. Others

9. Global Structural Heart Imaging Market - By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Diagnosis*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Surgery

10. Global Structural Heart Imaging Market - By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user Segment
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Specialty Clinics
  • 10.4. Cardiac Centers
  • 10.5. Diagnostic Centers
  • 10.6. Ambulatory Surgical Centers
  • 10.7. Others

11. Global Structural Heart Imaging Market - By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Global Structural Heart Imaging Market - Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Global Structural Heart Imaging Market- Company Profiles

  • 13.1. Boston Scientific Corporation*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Circle Cardiovascular Imaging Inc.
  • 13.3. Absolute Medical Services, Inc.
  • 13.4. Pie Medical Imaging B.V.
  • 13.5. Siemens Healthineers GmbH
  • 13.6. Cardinal Health Inc.
  • 13.7. Koninklijke Philips NV
  • 13.8. GE HealthCare
  • 13.9. Neusoft Medical Systems
  • 13.10. Shimadzu Corporation

LIST NOT EXHAUSTIVE

14. Global Structural Heart Imaging Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us